Clostridium botulinum A str. ATCC 3502

Clostridium_botulinum
Names Clostridium botulinum A str. ATCC 3502
Accession numbers NC_009495, NC_009496
Background Clostridium botulinum produces botulinum neurotoxin, one of deadliest toxins known. It inhibits acetylcholine release in neuromuscular junctions, causing paralysis by inhibiting muscle contraction. In most cases the affected person dies of asphyxiation or heart failure. Strains of C. botulinum are physiologically heterogeneous, and four distinct phenotypic groups (I to IV) are recognized. These four metabolically distinct groups do not, however, necessarily correlate with the serological specificities of the botulinum neurotoxin produced, which are classified into 7 serotypes, A-F. The type A toxin is used in minute doses to treat both painful muscle spasms and as a cosmetic treatment to temporarily remove frown lines between eyebrows. Strain Hall, ATCC 3502, is a representative of the Group I (proteolytic) botulinum toxin producing bacteria. Group I strains produce one or two toxins of type A, B or F; strain Hall produces type A1 neurotoxin. Food-borne, infant and wound botulism can all be caused by Group I strains. Strain Hall, the most widely studied of the C.botulinum strains, has been found to have an active chitinolytic system, enabling it to colonize environments where chitin-containing organism such as fungi, insects and crustaceans are abundant. Additionally it produces several extracellular proteases, presumably helping it to soften and destroy rotting or decaying tissues to support its saprophytic lifestyle. Two representatives of this strain have been sequenced, one of which contains a plasmid that encodes a bacteriocin boticin-like synthetic and transport system which may enable the bacteria to compete against other microbes. (EBI Integr8)
Taxonomy
Kingdom:Bacteria
Phylum:Firmicutes
Class:Clostridia
Order:Clostridiales
Family:Clostridiaceae
Genus:Clostridium
Species:botulinum
Strain A str. ATCC 3502
Complete Yes
Sequencing centre (04-JAN-2007) National Center for Biotechnology Information, NIH, Bethesda, MD 20894, USA
(21-NOV-2006) Sebaihia M., Sulston Laboratories, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton,
Sequencing quality Level 6: Finished
Sequencing depth NA
Sequencing method Sanger
Isolation site NA
Isolation country NA
Number of replicons 2
Gram staining properties Positive
Shape Bacilli
Mobility Yes
Flagellar presence Yes
Number of membranes 1
Oxygen requirements Anaerobic
Optimal temperature 37.0
Temperature range Mesophilic
Habitat Multiple
Biotic relationship Free living
Host name Homo sapiens
Cell arrangement Chains, Pairs, Singles
Sporulation Sporulating
Metabolism Type A toxin producer
Energy source Chemoorganotroph
Diseases Botulism
Pathogenicity Yes